Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Why This Analyst Says It's 'Simply A Good Time To Buy' Simply Good Foods

The recent pullback in Simply Good Foods Co.’s (NASDAQ: SMPL) shares offers “an attractive entry point” into a company offering stable growth in a volatile market, according to Stephens.

What 7 Analyst Ratings Have To Say About Tractor Supply

What 7 Analyst Ratings Have To Say About Tractor Supply

Within the last quarter, Tractor Supply (NASDAQ:TSCO) has observed the following analyst ratings:

9 Analysts Have This to Say About Ollie's Bargain Outlet

9 Analysts Have This to Say About Ollie's Bargain Outlet

Over the past 3 months, 9 analysts have published their opinion on Ollie's Bargain Outlet (NASDAQ:OLLI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Expert Ratings for MarketAxess Holdings

MarketAxess Holdings (NASDAQ:MKTX) has observed the following analyst ratings within the last quarter:

WM Technology And Compass Diversified Both Join Russell 2000 And 3000 Indexes

WM Technology, Inc. (NASDAQ: MAPS) has been added to the Russell 3000, Russell 2000 and Russell Microcap indexes and Compass Diversified (NYSE: CODI) has been added to the Russell 2000 and 3000 in

The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies

Here's a roundup of top developments in the biotech space over the last 24 hours:

Axsome Therapeutics Rallies 40% On FDA Product Label Proposal, But Analyst Remains Skeptical

Axsome Therapeutics Inc (NASDAQ: AXSM) shares rallied 40% on Monday morning after the company received some positive news from the U.S. Food and Drug Administration regarding its AXS-05 novel treatment for MDD (depression).

inkl

Read news from The Economist, FT, and more,
with one subscription

Artelo Biosciences Reveals Positive Pre-Clinical Results Of ART26.12, A Novel FABP5 Inhibitor, In Alleviating Chemotherapy-Induced Pain

Artelo Biosciences Reveals Positive Pre-Clinical Results Of ART26.12, A Novel FABP5 Inhibitor, In Alleviating Chemotherapy-Induced Pain

Professor Saoirse O’Sullivan, vice president of translational sciences at Artelo Biosciences Inc., (NASDAQ: ARTL) presented new research results entitled, “Discovery and pre

Alec Baldwin To Interview Woody Allen On Instagram: What You Need To Know

Alec Baldwin To Interview Woody Allen On Instagram: What You Need To Know

Alec Baldwin is taking on the role of interviewer with actor/filmmaker Woody Allen, which will be presented on June 28 at 10:30 a.m. EDT on Baldwin’s Instagram page.

Greenlane Secures $5.4M Via Registered Direct Offering

Greenlane Secures $5.4M Via Registered Direct Offering

Greenlane Holdings, Inc. (NASDAQ: GNLN) has entered into a definitive agreement with a single institutional investor, for the purchase and sale of 21.6 million shares of its common stock and warrants to purchase 21.6 million shares of common stock at a purchase price per share of $0

Analyst Ratings for Texas Roadhouse

Analyst Ratings for Texas Roadhouse

Analysts have provided the following ratings for Texas Roadhouse (NASDAQ:TXRH) within the last quarter:

Preview: Cognyte Software's Earnings

Preview: Cognyte Software's Earnings

Cognyte Software (NASDAQ:CGNT) is set to give its latest quarterly earnings report on Tuesday, 2022-06-28. Here's what investors need to know before the announcement. Analysts estimate that Cognyte Software will report an earnings per share (EPS) of $0.10.

Earnings Outlook For Beyond Air

Earnings Outlook For Beyond Air

Beyond Air (NASDAQ:XAIR) is set to give its latest quarterly earnings report on Tuesday, 2022-06-28. Here's what investors need to know before the announcement. Analysts estimate that Beyond Air will report an earnings per share (EPS) of $-0.27.

Earnings Preview For Progress Software

Earnings Preview For Progress Software

Progress Software (NASDAQ:PRGS) is set to give its latest quarterly earnings report on Tuesday, 2022-06-28. Here's what investors need to know before the announcement. Analysts estimate that Progress Software will report an earnings per share (EPS) of $0.95.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2022

U.S. Markets Open Lower; Durable Goods Orders Rise 0.7%

U.S. stocks traded lower this morning, with the Nasdaq Composite dropping over 100 points on Monday.

5 Short Squeeze Candidate To Watch This Week: Redbox And Chicken Soup For The Soul Both In Top Five, Revlon Remains On Leaderboard

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move.

Apple Mixed Reality Headset Could Feature The Powerful M2 Chip

Apple Inc (NASDAQ: AAPL) could use the recently announced M2 chip in its rumored mixed-reality headset.

Get all your
news in one place.

100's of premium titles.
One news app.

Comtech Telecomms's Return On Capital Employed Overview

According to Benzinga Pro data, during Q3, Comtech Telecomms (NASDAQ:CMTL) posted sales of $122.12 million. Earnings were up 99.89%, but Comtech Telecomms still reported an overall loss of $25.00 thousand.

Broker Quantfury Makes Money For Users, Builds 'Hedge Fund For The Masses'

Benzinga, a media and data provider bridging the gap between retail and institutional investors, will be bringing back its annual Global Fintech Awards event to New York City on Dec. 8.

Looking Into Mission Produce's Return On Invested Capital

According to Benzinga Pro, during Q2, Mission Produce (NASDAQ:AVO) earned $2.40 million, a 117.91% increase from the preceding quarter. Mission Produce also posted a total of $278.10 million in sales, a 28.39% increase since Q1.

Looking Into Lovesac's Return On Capital Employed

According to Benzinga Pro, during Q1, Lovesac (NASDAQ:LOVE) earned $1.90 million, a 94.19% increase from the preceding quarter. Lovesac's sales decreased to $129.38 million, a 34.06% change since Q4.

Ollie's Bargain Outlet Earnings Perspective: Return On Capital Employed

Pulled from Benzinga Pro data, Ollie's Bargain Outlet (NASDAQ:OLLI) posted Q1 earnings of $12.52 million, an increase from Q4 of 72.0%. Sales dropped to $406.67 million, a 18.85% decrease between quarters.

Looking Into Academy Sports's Return On Capital Employed

According to Benzinga Pro, during Q1, Academy Sports (NASDAQ:ASO) earned $149.81 million, a 5.67% increase from the preceding quarter. Academy Sports's sales decreased to $1.47 billion, a 18.81% change since Q4.

Looking Into Verint Systems's Return On Invested Capital

Pulled from Benzinga Pro data, Verint Systems (NASDAQ:VRNT) posted Q1 earnings of $574.00 thousand, an increase from Q4 of 113.47%. Sales dropped to $219.25 million, a 7.17% decrease between quarters.

1 … 378 379 380 381

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Bed, Bath & Beyond

Chipotle Mexican Grill

Robinhood Markets

Coinbase Global

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

374,962 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play